Drug Type Monoclonal antibody |
Synonyms IPG 0521, IPG0521 |
Target |
Action inhibitors |
Mechanism CCR8 inhibitor(C-C motif chemokine receptor 8 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseIND Approval |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Advanced Malignant Solid Neoplasm | IND Approval | China | 05 Sep 2025 | |
Immunoglobulin G4-Related Disease | IND Application | China | 01 Aug 2025 |